TESTIMONIALS

“Received the latest edition of Professional Security Magazine, once again a very enjoyable magazine to read, interesting content keeps me reading from front to back. Keep up the good work on such an informative magazine.”

Graham Penn
ALL TESTIMONIALS
FIND A BUSINESS

Would you like your business to be added to this list?

ADD LISTING
FEATURED COMPANY
Biometrics

Palm vein recognition for stadia

by Mark Rowe

The Hungarian security company, BioSec Group Ltd is attending a stadium industry event with Fujitsu. The companies will exhibit at the Arena Summit in Germany, on November 20 and 21. They will demonstrate their stadium security concept based on palm vein recognition.

BioSec’s stadium security and service solution package, the StadiumGuard, will be demonstrated in an interactive way, for visitors can learn more. According to the exhibitors, the system provides a zero tolerance concept for football violence. StadiumGuard is described by the firms as the last brick in the line of technologies to be able to create really personalised tickets, keeping banned people outside the stadium. Using the technology, family-friendly stadiums can be created, literally with the wave of the hand with palm vein recognition-based biometric personal authentication. By using the system, visitors can access the stadium by hovering their hands above the vein scanner, which provides authentication under a second, it’s claimed. According to BioSec Group CEO, Péter Györgydeák, “Violence-free sports events and family-friendly stadiums are not magic. It is “just” technology.”

The companies will be at booth number 4 at the Commerzbank-Arena Frankfurt. Visit https://www.arena-summit.de/.

Event speakers include Henk Markerink, CEO of the AmsterdamArena; and Steve Schwenkglenks, General Manager, Barclaycard Arena in Hamburg.

Related News

  • Biometrics

    Cyber round-up

    by Mark Rowe

    Biometrics ranked as the authentication method consumers consider the best login experience and the method they consider most secure for a second…